elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38669051-88C587EE-952F-4167-8CC4-D004B409534D
Q38669051-88C587EE-952F-4167-8CC4-D004B409534D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38669051-88C587EE-952F-4167-8CC4-D004B409534D
Unique features of trabectedin mechanism of action.
P2860
Q38669051-88C587EE-952F-4167-8CC4-D004B409534D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38669051-88C587EE-952F-4167-8CC4-D004B409534D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3b9e864293388a6d78297440dab4b698b2d879d5
P2860
Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells.